SLNO - Soleno draws Buy from Guggenheim on rare disease therapy
2023-11-21 13:57:21 ET
More on Soleno
- Soleno Therapeutics prices its underwritten public offering at $20 per share
- Soleno Therapeutics proposes public offering of common stock
- Seeking Alpha’s Quant Rating on Soleno Therapeutics
- Historical earnings data for Soleno Therapeutics
- Financial information for Soleno Therapeutics
For further details see:
Soleno draws Buy from Guggenheim on rare disease therapy